Avirmax CMC Successfully Delivers First GMP Lot of AAV Vector Product for Clinical Trial Use ...Middle East

HAYWARD, Calif., July 17, 2024 /PRNewswire/ -- Avirmax CMC, a leader in the innovation and manufacture of adeno-associated virus (AAV) vector-mediated biotherapeutics, announces the successful delivery to its first client with Good Manufacturing Practice (GMP) lots of AAV vector product...

Hence then, the article about avirmax cmc successfully delivers first gmp lot of aav vector product for clinical trial use was published today ( Thursday 18/07/2024 - 12:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Avirmax CMC Successfully Delivers First GMP Lot of AAV Vector Product for Clinical Trial Use )

Also on site :

• Worldline and EcoFlow announce strategic partnership to power seamless global payments
• Booths Filling Fast: Industrial Technology World Asia Vietnam 2026 Targets ASEAN's Manufacturing Boom
• SAP und Cyberwave setzen vollständig autonome, KI-gestützte Roboter in einem realen SAP-Logistiklager ein